Neutral on Biogen – Zacks.com
Neutral on BiogenZacks.comOther interesting candidates in the MS pipeline daclizumab, which is being developed in collaboration with Abbott Labs (ABT), and PEGylated interferon. Biogen's pipeline also has candidates for other ailments like amyotrop…